MSDS

Page 7 of 10
Component Information
Chemical Name Oral LD50 Dermal LD50 Inhalation LC50
Titanium dioxide > 10000 mg/kg (Rat)
13463-67-7
Iron oxide 3.03 mg/kg (Rat) 100 mg/kg (Rat) No data available
1309-37-1
Solvent naphtha, No data available No data available No data available
Light aromatic
64742-95-6
Methyl amyl ketone LD50: (Rat) LD50: (Rat) No data available
110-43-0 1,600 mg/kg >2,000 mg/kg
Information on Toxicological Effects
Symptoms
May cause redness and tearing of the eyes, coughing and/or wheezing, itching, rashes and hives.
Delayed and Immediate Effects as well as Chronic Effects from Short and Long-Term Exposure
Sensitization
May cause sensitization of susceptible persons. May cause sensitization by skin contact.
Mutagenic Effects
No information available
Carcinogenicity
The table below indicates whether each agency has listed any ingredient as a carcinogen
Chemical Name ACGIH IARC NTP OSHA
Titanium dioxide Group 2B X
13463-67-7
ACGIH (American Conference of Governmental Industrial Hygienists)
A2 – Suspected Human Carcinogen
IARC (International Agency for Research on Cancer)
Group 2B – Possibly Carcinogenic to Humans
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X-Present
Reproductive Toxicity, STOT Single Exposure, STOT Repeated Exposure:
No information available
Chronic Toxicity
Titanium dioxide has been classified by the International Agency for Research on Cancer (IARC) as
possibly carcinogenic to humans (Group 2B) by inhalation. Contains a known or suspected carcinogen.
Target Organ Effects
Eyes, respiratory system, skin, gastrointestinal tract (GI) & lungs.